Dupilumab Significantly Reduces Itch and Hives in Patients With Chronic Spontaneous Urticaria: Results From a Phase 3 Trial (LIBERTY-CSU CUPID Study A)
Marcus Maurer, Thomas B. Casale, Sarbjit Saini, Moshe Ben‐Shoshan, Nikhil Amin, Allen Radin, Bolanle Akinlade, Chunpeng Fan, Déborah Bauer, Elizabeth Laws, Leda Mannent, Aleksandra Stjepanovic
Topics & Concepts
MedicineAngioedemaDupilumabQuality of life (healthcare)DiseaseHereditary angioedemaChronic urticariaDermatologyAtopic dermatitisInternal medicineNursingUrticaria and Related ConditionsAutoimmune Bullous Skin DiseasesMast cells and histamine